Aptamers Market, By Type (Nucleic Acid, and Peptides (DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers)), By Application (Diagnostics, Therapeutics, and Research and Development), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa) - Trends, Analysis and Forecast Till 2034

Report Code: PMI387920 | Publish Date: March 2024 | No. of Pages: 168

Global Aptamers Market By Market Companies

  • Somalogic, Inc.
  • Noxxan Pharma AG
  • Aptamer Science Inc.
  • Aptagen
  • Inc
  • AM Biotechnologies LLC
  • Aptamer Solutions Ltd.
  • Aptus Biotech S.L.
  • Base Pair Biotechnologies Inc.
  • NeoVentures Biotechnology Inc.
  • TriLink BioTechnologies, Inc.

Recent News:

  • In October 2023, Zentek Announces the Launch of Subsidiary for Aptamer-Based Platform Technology. This new entity has been launched to foster collaboration and licensing agreements with the pharmaceutical industry, this new business aims to disseminate the aptamer technology to prospective biotech investors and expedite its growth. This licensing agreement covers the recent aptamer-based platform technology and the rapid-detection platform created by Dr. Yingfu Li and his team, which is demonstrating therapeutic potential in preclinical trials being carried out by Dr. Matthew Miller and his colleagues.